Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06411132 | RECRUITING | Sjögren Syndrome

Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
Sponsor:

Dompé Farmaceutici S.p.A

Brief Summary:

Primary Objective - To assess the proportion of patients with Sjögren's dry eye who demonstrate impaired corneal sensitivity. Secondary Objectives * To assess corneal sensitivity via Cochet-Bonnet esthesiometer. * To assess tear secretion via Schirmer I test. * To assess OPAS questionnaire results.

Condition or disease

Sjogren's Syndrome

Dry Eye

Intervention/treatment

observational study

Detailed Description:

This clinical study has been designed to evaluate the proportion of patients with confirmed Sjögren's dry eye who present with neurosensory abnormalities via demonstration of increased ocular pain and/or a decrease in corneal sensitivity. A multicenter design allows for a greater diversity of patient population with Sjögren's dry eye. The number of sites allows for quick enrollment and expedited results that will help physicians understand the corneal sensitivity levels in the population of patients with Sjögren's dry eye. This study design is minimally invasive and may be completed in a single visit provided all qualification criteria are met. This design reduces the time commitment from patients, thereby reducing barriers for enrollment and participation.

Study Type : OBSERVATIONAL
Estimated Enrollment : 182 participants
Official Title : A Multicenter, Observational Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye
Actual Study Start Date : 2024-05-09
Estimated Primary Completion Date : 2025-02-03
Estimated Study Completion Date : 2025-02-03

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Patient must be ≥18 years of age at time of screening.
  • 2. Patient must have had a confirmed diagnosis of Sjögren's for a minimum of 3 months before enrollment, as determined by either serologic antibody testing (anti-SSA/anti-SSB) or biopsy of minor salivary glands.
  • 3. Patient must have had a confirmed diagnosis of dry eye for a minimum of 3 months before enrollment, as determined by signs and/or symptom assessment.
  • 4. Fluorescein corneal staining with a cobalt blue light must show punctate corneal fluorescein staining or staining consistent with corneal epithelial damage equivalent or greater than 1 on the NEI scale by dry eye at enrollment.
  • 5. Only patients who satisfy all informed consent requirements may be included in the study. The patient and/or his/her legal representative must read, sign, and date the IRB-approved informed consent document before any study-related procedures are performed.
  • 6. Patients must have the ability and willingness to comply with study procedures.
Exclusion Criteria
  • 1. Inability to speak and understand English sufficiently to understand the nature of the study, provide written informed consent, and allow the completion of all study assessments.
  • 2. Presence of active ocular infection (bacterial, viral, protozoal) in either eye, as deemed by the Investigator or confirmed culture.
  • 3. Previous use of OXERVATE® ophthalmic solution.
  • 4. Presence of gross epithelial defect, including a defect with stromal involvement.
  • 5. Any concurrent medical condition that, in the judgment of the Investigator, might interfere with the conduct of the study or confound the interpretation of the study results.
  • 6. Any eyelid abnormalities, such as lagophthalmos, entropion, ectropion, or other neuromuscular abnormalities, that result in prolonged exposure of the corneal surface.
  • 7. Concurrent epithelial corneal disease or dystrophy unrelated to dry eye, such as anterior basement membrane dystrophy.
  • 8. Inability to remove contact lenses for a minimum of 3 hours before corneal sensitivity testing.
  • 9. Inability to discontinue use of all topical ophthalmic treatments for a minimum of 3 hours before corneal sensitivity testing.
  • 10. Inability to suspend use of any neurostimulatory drugs or devices (including but not limited to nasal varenicline, iTear100, etc.) for treating dry eye or increasing tear film for 6 hours before testing.
  • 11. Ocular surgery (including but not limited to laser-assisted in situ keratomileusis, photorefractive keratectomy, tube shunt/trabeculectomy, or cataract surgery) within the last 6 months.
  • 12. History of corneal stromal surgery, including anterior lamellar keratoplasty, deep anterior lamellar keratoplasty, and penetrating keratoplasty.
  • 13. Current participation in another clinical study that may affect corneal sensitivity or tear production.
Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye

Location Details

NCT06411132

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, California

West Coast Eye Institute

Bakersfield, California, United States, 11901

RECRUITING

United States, Colorado

University of Colorado

Aurora, Colorado, United States, 80045

RECRUITING

United States, Florida

Bowden Eye

Jacksonville, Florida, United States, 32256

RECRUITING

United States, Florida

University of Miami

Miami, Florida, United States, 33136

RECRUITING

United States, Massachusetts

Tufts University School of Medicine

Boston, Massachusetts, United States, 02111

RECRUITING

United States, Minnesota

Minnesota Eye Consultants

Woodbury, Minnesota, United States, 55125

RECRUITING

United States, New Jersey

Eye Associates of North Jersey

Dover, New Jersey, United States, 07801

RECRUITING

United States, New York

Weil Cornell Medicine

New York, New York, United States, 10021

RECRUITING

United States, North Carolina

Triangle Eye Consultants

Raleigh, North Carolina, United States, 27617

RECRUITING

United States, North Carolina

Vita Eye Clinic

Shelby, North Carolina, United States, 28150

RECRUITING

United States, North Carolina

Focus Eye Care

Wilmington, North Carolina, United States, 28405

RECRUITING

United States, Pennsylvania

University of Pennsylvania

Philadelphia, Pennsylvania, United States, 19104

RECRUITING

United States, Tennessee

Toyos Clinic

Nashville, Tennessee, United States, 37215

RECRUITING

United States, Washington

Periman Eye Institute

Seattle, Washington, United States, 98119